-
Analyst Opinions
Top Trends in Packaging – Industry Insights
Reasons to buy the ‘Top Trends in Packaging’ industry insight report: Assess the top trends affecting the packaging industry across the themes of the market, the environment, and technology. Market Trends - Shrinkflation and Winning at Shelf Environment Trends - Regulation for environmental change to value sustainable packaging Technology Trends - Material Evolution, Tech Enablers for Smart Supply Chains and Automation in Packaging Machinery The report is driven by GlobalData's Mega-trend Survey Analysis, primary consumer research that periodically compares the magnitude of...
-
Thematic Analysis
Insurance Predictions in 2024 – Thematic Intelligence
Accessing in-depth insights from the ‘Insurance Predictions in 2024’ report will help in: Analyzing the major themes that will impact the insurance industry in 2024. Identifying the top 15 themes impacting the insurance industry - Personalization, Wellbeing, Embedded Insurance, Insurtech, Parametric Insurance, Cyber Insurance, ESG - Environmental (Nat Cat), Electric Vehicles, AI, Big Data, IoT, Future of Work, Inflation, ESG, and Geopolitics. Exploring a wide range of capabilities that insurers, reinsurers, and brokers can utilize to transform their services and...
-
Sector Analysis
Czech Republic Defense Market Size, Trends, Budget Allocation, Regulations, Acquisitions, Competitive Landscape and Forecast to 2028
Czech Republic Defense Market Report Overview As of 2023, the Czech Republic defense budget was worth $4.7 billion. The country’s defense budget is set to see high levels of growth, registering a CAGR of more than 9% between 2024 and 2028. Factors such as the significant changes in the defense and security posture of the Czech Republic as a result of Russia’s 2022 full-scale invasion of Ukraine and expansion of military capability are driving the Czech Republic's defense market growth....
-
Thematic Analysis
Banking Predictions for 2024 – Thematic Intelligence
Exploring in-depth trends and insights from the ‘Banking Predictions for 2024’ report will enable you to: Analyze the major themes that will impact the banking industry in 2024. Identify the top 20 themes impacting the banking industry – artificial intelligence, cybersecurity, the future of work, cloud computing, blockchain and cryptocurrencies, fintech, internet of things, big data, social media, financial wellness, digital lending, digital banking, conversational platforms, personalization, data privacy, and open banking. Understand a wide range of disruptive themes that...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Melanoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Melanoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Melanoma Drug Details: PD-L1/IDO (IO102/IO103) peptide vaccine...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Hypopharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Hypopharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Hypopharyngeal Cancer Drug Details: PD-L1/IDO (IO102/IO103)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Laryngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Laryngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Laryngeal Cancer Drug Details: PD-L1/IDO (IO102/IO103)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Oropharyngeal Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Oropharyngeal Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Oropharyngeal Cancer Drug Details: PD-L1/IDO (IO102/IO103)...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Oral Cavity (Mouth) Cancer
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Oral Cavity (Mouth) Cancer report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Oral Cavity (Mouth) Cancer...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – (IO-102 + IO-103) in Lung Adenocarcinoma
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - (IO-102 + IO-103) in Lung Adenocarcinoma report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. (IO-102 + IO-103) in Lung Adenocarcinoma Drug Details: PD-L1/IDO (IO102/IO103)...